ID   LPIN1_HUMAN             Reviewed;         890 AA.
AC   Q14693; A8MU38; B4DET9; B4DGS4; B4DGZ6; B5MC18; B7Z858; D6W506;
AC   E7ESE7; F5GY24; Q53T25;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 2.
DT   10-MAY-2017, entry version 148.
DE   RecName: Full=Phosphatidate phosphatase LPIN1;
DE            EC=3.1.3.4;
DE   AltName: Full=Lipin-1;
GN   Name=LPIN1; Synonyms=KIAA0188;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V.
RT   The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 4), AND
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 481-890 (ISOFORM 3).
RC   TISSUE=Brain, Cerebellum, Testis, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 6), AND VARIANT
RP   THR-637.
RC   TISSUE=Hippocampus, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=17158099; DOI=10.1074/jbc.M610745200;
RA   Donkor J., Sariahmetoglu M., Dewald J., Brindley D.N., Reue K.;
RT   "Three mammalian lipins act as phosphatidate phosphatases with
RT   distinct tissue expression patterns.";
RL   J. Biol. Chem. 282:3450-3457(2007).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   BIOPHYSICOCHEMICAL PROPERTIES (ISOFORMS 1; 3 AND 4), ENZYME
RP   REGULATION, AND COFACTOR.
RX   PubMed=20231281; DOI=10.1074/jbc.M110.117747;
RA   Han G.S., Carman G.M.;
RT   "Characterization of the human LPIN1-encoded phosphatidate phosphatase
RT   isoforms.";
RL   J. Biol. Chem. 285:14628-14638(2010).
RN   [10]
RP   VARIANT SER-610.
RX   PubMed=12111372; DOI=10.1007/s100380200052;
RA   Cao H., Hegele R.A.;
RT   "Identification of single-nucleotide polymorphisms in the human LPIN1
RT   gene.";
RL   J. Hum. Genet. 47:370-372(2002).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-56.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [12]
RP   INVOLVEMENT IN ARARM.
RX   PubMed=18817903; DOI=10.1016/j.ajhg.2008.09.002;
RA   Zeharia A., Shaag A., Houtkooper R.H., Hindi T., de Lonlay P.,
RA   Erez G., Hubert L., Saada A., de Keyzer Y., Eshel G., Vaz F.M.,
RA   Pines O., Elpeleg O.;
RT   "Mutations in LPIN1 cause recurrent acute myoglobinuria in
RT   childhood.";
RL   Am. J. Hum. Genet. 83:489-494(2008).
RN   [13]
RP   ERRATUM.
RA   Zeharia A., Shaag A., Houtkooper R.H., Hindi T., de Lonlay P.,
RA   Erez G., Hubert L., Saada A., de Keyzer Y., Eshel G., Vaz F.M.,
RA   Pines O., Elpeleg O.;
RL   Am. J. Hum. Genet. 84:95-95(2008).
RN   [14]
RP   TISSUE SPECIFICITY.
RX   PubMed=22134922; DOI=10.1074/jbc.M111.324350;
RA   Han S., Bahmanyar S., Zhang P., Grishin N., Oegema K., Crooke R.,
RA   Graham M., Reue K., Dixon J.E., Goodman J.M.;
RT   "Nuclear envelope phosphatase-regulatory subunit 1 (formerly TMEM188)
RT   is the metazoan SPO7 ortholog and functions in the lipin activation
RT   pathway.";
RL   J. Biol. Chem. 287:3123-3137(2012).
CC   -!- FUNCTION: Plays important roles in controlling the metabolism of
CC       fatty acids at different levels. Acts as a magnesium-dependent
CC       phosphatidate phosphatase enzyme which catalyzes the conversion of
CC       phosphatidic acid to diacylglycerol during triglyceride,
CC       phosphatidylcholine and phosphatidylethanolamine biosynthesis in
CC       the reticulum endoplasmic membrane. Acts also as a nuclear
CC       transcriptional coactivator for PPARGC1A/PPARA to modulate lipid
CC       metabolism gene expression (By similarity). Is involved in
CC       adipocyte differentiation. May also be involved in mitochondrial
CC       fission by converting phosphatidic acid to diacylglycerol (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: A 1,2-diacylglycerol 3-phosphate + H(2)O = a
CC       1,2-diacyl-sn-glycerol + phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:20231281};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:20231281};
CC       Note=Mg(2+) and, at a lesser extent, Mn(2+).
CC       {ECO:0000269|PubMed:20231281};
CC   -!- ENZYME REGULATION: Potently inhibited by sphingolipids, in
CC       particular, the sphingoid bases sphinganine and sphingosine and
CC       ceramide-1-phosphate. Inhibited by concentrations of Mg(2+) and
CC       Mn(2+) above their optimums and by Ca(2+), Zn(2+), N-
CC       ethylmaleimide and propranolol. {ECO:0000269|PubMed:20231281}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.35 mM for phosphatidate (isoform 1);
CC         KM=0.24 mM for phosphatidate (isoform 3);
CC         KM=0.11 mM for phosphatidate (isoform 4);
CC       Temperature dependence:
CC         Optimum temperature is 40 degrees Celsius. Thermolabile above 40
CC         degrees Celsius and essentially inactive at 60 degrees Celsius.;
CC   -!- SUBUNIT: Interacts (via LXXIL motif) with PPARA. Interacts with
CC       PPARGC1A. Interaction with PPARA and PPARGC1A leads to the
CC       formation of a complex that modulates gene transcription.
CC       Interacts with MEF2C. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250}. Cytoplasm,
CC       cytosol {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=Q14693-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14693-2; Sequence=VSP_045533;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=Beta;
CC         IsoId=Q14693-3; Sequence=VSP_053970;
CC       Name=4; Synonyms=Gamma;
CC         IsoId=Q14693-4; Sequence=VSP_053971;
CC       Name=5;
CC         IsoId=Q14693-5; Sequence=VSP_045533, VSP_053970;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q14693-6; Sequence=VSP_045533, VSP_053970, VSP_055361,
CC                                  VSP_055362;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=Q14693-7; Sequence=VSP_055384, VSP_053970;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Specifically expressed in skeletal muscle.
CC       Also abundant in adipose tissue. Lower levels in some portions of
CC       the digestive tract. {ECO:0000269|PubMed:17158099,
CC       ECO:0000269|PubMed:22134922}.
CC   -!- DOMAIN: Contains one Leu-Xaa-Xaa-Ile-Leu (LXXIL), a
CC       transcriptional binding motif, which mediates interaction with
CC       PPARA. {ECO:0000250}.
CC   -!- DOMAIN: Contains 1 Asp-Xaa-Asp-Xaa-Thr (DXDXT) motif, a catalytic
CC       motif essential for phosphatidate phosphatase activity.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated at multiple sites in response to insulin.
CC       Phosphorylation is controlled by the mTOR signaling pathway.
CC       Phosphorylation is decreased by epinephrine. Phosphorylation may
CC       not directly affect the catalytic activity but may regulate the
CC       localization. Dephosphorylated by the CTDNEP1-CNEP1R1 complex (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Sumoylated. {ECO:0000250}.
CC   -!- DISEASE: Myoglobinuria, acute recurrent, autosomal recessive
CC       (ARARM) [MIM:268200]: Recurrent myoglobinuria is characterized by
CC       recurrent attacks of rhabdomyolysis (necrosis or disintegration of
CC       skeletal muscle) associated with muscle pain and weakness and
CC       followed by excretion of myoglobin in the urine. Renal failure may
CC       occasionally occur. {ECO:0000269|PubMed:18817903}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: May represent a candidate gene for human
CC       lipodysytropy syndromes.
CC   -!- SIMILARITY: Belongs to the lipin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA11505.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAG57200.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG57885.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAG57957.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BC018071; Type=Frameshift; Positions=134; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D80010; BAA11505.1; ALT_INIT; mRNA.
DR   EMBL; AK290235; BAF82924.1; -; mRNA.
DR   EMBL; AK293787; BAG57200.1; ALT_INIT; mRNA.
DR   EMBL; AK294742; BAG57885.1; ALT_INIT; mRNA.
DR   EMBL; AK294853; BAG57957.1; ALT_INIT; mRNA.
DR   EMBL; AK302922; BAH13844.1; -; mRNA.
DR   EMBL; AC012456; AAY14695.1; -; Genomic_DNA.
DR   EMBL; AC106875; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAX00918.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00920.1; -; Genomic_DNA.
DR   EMBL; BC018071; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC030537; AAH30537.1; -; mRNA.
DR   CCDS; CCDS1682.1; -. [Q14693-1]
DR   CCDS; CCDS58699.1; -. [Q14693-7]
DR   CCDS; CCDS58701.1; -. [Q14693-2]
DR   RefSeq; NP_001248356.1; NM_001261427.1. [Q14693-2]
DR   RefSeq; NP_001248357.1; NM_001261428.1. [Q14693-7]
DR   RefSeq; NP_001248358.1; NM_001261429.1. [Q14693-6]
DR   RefSeq; NP_663731.1; NM_145693.2. [Q14693-1]
DR   RefSeq; XP_006711933.1; XM_006711870.3. [Q14693-5]
DR   RefSeq; XP_006711934.1; XM_006711871.2. [Q14693-3]
DR   RefSeq; XP_006711935.1; XM_006711872.2. [Q14693-3]
DR   RefSeq; XP_006711937.1; XM_006711874.2. [Q14693-3]
DR   RefSeq; XP_011508636.1; XM_011510334.2. [Q14693-5]
DR   RefSeq; XP_011508637.1; XM_011510335.2. [Q14693-3]
DR   RefSeq; XP_011508638.1; XM_011510336.2. [Q14693-3]
DR   RefSeq; XP_016859113.1; XM_017003624.1. [Q14693-3]
DR   RefSeq; XP_016859114.1; XM_017003625.1. [Q14693-3]
DR   RefSeq; XP_016859117.1; XM_017003628.1. [Q14693-1]
DR   RefSeq; XP_016859118.1; XM_017003629.1. [Q14693-1]
DR   RefSeq; XP_016859119.1; XM_017003630.1. [Q14693-1]
DR   UniGene; Hs.467740; -.
DR   UniGene; Hs.739141; -.
DR   ProteinModelPortal; Q14693; -.
DR   BioGrid; 116787; 9.
DR   IntAct; Q14693; 3.
DR   STRING; 9606.ENSP00000256720; -.
DR   SwissLipids; SLP:000000881; -. [Q14693-1]
DR   SwissLipids; SLP:000000882; -. [Q14693-3]
DR   SwissLipids; SLP:000000883; -. [Q14693-4]
DR   DEPOD; Q14693; -.
DR   iPTMnet; Q14693; -.
DR   PhosphoSitePlus; Q14693; -.
DR   BioMuta; LPIN1; -.
DR   DMDM; 23831266; -.
DR   EPD; Q14693; -.
DR   MaxQB; Q14693; -.
DR   PaxDb; Q14693; -.
DR   PeptideAtlas; Q14693; -.
DR   PRIDE; Q14693; -.
DR   DNASU; 23175; -.
DR   Ensembl; ENST00000256720; ENSP00000256720; ENSG00000134324. [Q14693-1]
DR   Ensembl; ENST00000396097; ENSP00000379404; ENSG00000134324. [Q14693-5]
DR   Ensembl; ENST00000396098; ENSP00000379405; ENSG00000134324. [Q14693-6]
DR   Ensembl; ENST00000425416; ENSP00000401522; ENSG00000134324. [Q14693-2]
DR   Ensembl; ENST00000449576; ENSP00000397908; ENSG00000134324. [Q14693-7]
DR   GeneID; 23175; -.
DR   KEGG; hsa:23175; -.
DR   UCSC; uc002rbs.5; human. [Q14693-1]
DR   CTD; 23175; -.
DR   DisGeNET; 23175; -.
DR   GeneCards; LPIN1; -.
DR   HGNC; HGNC:13345; LPIN1.
DR   HPA; HPA038021; -.
DR   MalaCards; LPIN1; -.
DR   MIM; 268200; phenotype.
DR   MIM; 605518; gene.
DR   neXtProt; NX_Q14693; -.
DR   OpenTargets; ENSG00000134324; -.
DR   Orphanet; 99845; Genetic recurrent myoglobinuria.
DR   PharmGKB; PA30436; -.
DR   eggNOG; KOG2116; Eukaryota.
DR   eggNOG; COG5083; LUCA.
DR   GeneTree; ENSGT00390000011286; -.
DR   HOGENOM; HOG000202965; -.
DR   HOVERGEN; HBG052338; -.
DR   InParanoid; Q14693; -.
DR   KO; K15728; -.
DR   OMA; NVQTMNY; -.
DR   OrthoDB; EOG091G01JU; -.
DR   PhylomeDB; Q14693; -.
DR   TreeFam; TF314095; -.
DR   BRENDA; 3.1.3.4; 2681.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-1483213; Synthesis of PE.
DR   Reactome; R-HSA-4419969; Depolymerisation of the Nuclear Lamina.
DR   Reactome; R-HSA-75109; Triglyceride Biosynthesis.
DR   SIGNOR; Q14693; -.
DR   ChiTaRS; LPIN1; human.
DR   GeneWiki; LPIN1; -.
DR   GenomeRNAi; 23175; -.
DR   PRO; PR:Q14693; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000134324; -.
DR   CleanEx; HS_LPIN1; -.
DR   ExpressionAtlas; Q14693; baseline and differential.
DR   Genevisible; Q14693; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IBA:GO_Central.
DR   GO; GO:0005635; C:nuclear envelope; TAS:Reactome.
DR   GO; GO:0031965; C:nuclear membrane; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0008195; F:phosphatidate phosphatase activity; EXP:Reactome.
DR   GO; GO:0003713; F:transcription coactivator activity; IBA:GO_Central.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0009062; P:fatty acid catabolic process; ISS:UniProtKB.
DR   GO; GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome.
DR   GO; GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006642; P:triglyceride mobilization; ISS:UniProtKB.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR031703; Lipin_mid.
DR   InterPro; IPR007651; Lipin_N.
DR   InterPro; IPR013209; LNS2.
DR   InterPro; IPR031315; LNS2/PITP.
DR   InterPro; IPR028794; LPIN1.
DR   PANTHER; PTHR12181:SF47; PTHR12181:SF47; 1.
DR   Pfam; PF16876; Lipin_mid; 1.
DR   Pfam; PF04571; Lipin_N; 1.
DR   Pfam; PF08235; LNS2; 1.
DR   SMART; SM00775; LNS2; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; Fatty acid metabolism; Hydrolase;
KW   Isopeptide bond; Lipid metabolism; Membrane; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    890       Phosphatidate phosphatase LPIN1.
FT                                /FTId=PRO_0000209879.
FT   REGION        1    108       N-LIP.
FT   REGION      624    830       C-LIP.
FT   MOTIF       153    158       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF       678    682       DXDXT motif.
FT   MOTIF       689    693       LXXIL motif.
FT   COMPBIAS    147    150       Poly-Ser.
FT   COMPBIAS    598    601       Poly-Ser.
FT   MOD_RES     106    106       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     150    150       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     252    252       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     254    254       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     260    260       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     264    264       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     294    294       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     434    434       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     438    438       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     449    449       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     600    600       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     601    601       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     887    887       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   MOD_RES     889    889       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91ZP3}.
FT   CROSSLNK    565    565       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250}.
FT   CROSSLNK    595    595       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250}.
FT   VAR_SEQ       1      1       M -> MSRVQTM (in isoform 2, isoform 5 and
FT                                isoform 6). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045533.
FT   VAR_SEQ       1      1       M -> MGEQDGIRSSSWETSQGKSSPDSAWSWIPIMRDPGW
FT                                IRNVWSSNINVQTM (in isoform 7).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_055384.
FT   VAR_SEQ     241    241       S -> SSLVDCKRTAPHLAVAAEGGLSSSCPPQSSLFHPSE
FT                                S (in isoform 3, isoform 5, isoform 6 and
FT                                isoform 7). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_053970.
FT   VAR_SEQ     417    417       N -> K (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055361.
FT   VAR_SEQ     418    890       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055362.
FT   VAR_SEQ     535    535       K -> KSSCLSYLHVILDAIRFCFSKIFNAQI (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053971.
FT   VARIANT      56     56       G -> E (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035874.
FT   VARIANT     610    610       P -> S (in dbSNP:rs4669781).
FT                                {ECO:0000269|PubMed:12111372}.
FT                                /FTId=VAR_013885.
FT   VARIANT     637    637       S -> T (in dbSNP:rs17852755).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_054878.
FT   CONFLICT    171    171       D -> G (in Ref. 5; BC018071).
FT                                {ECO:0000305}.
FT   CONFLICT    210    210       D -> G (in Ref. 2; BAG57885).
FT                                {ECO:0000305}.
FT   CONFLICT    316    316       D -> Y (in Ref. 2; BAH13844).
FT                                {ECO:0000305}.
FT   CONFLICT    535    535       K -> R (in Ref. 2; BAH13844).
FT                                {ECO:0000305}.
FT   CONFLICT    592    592       T -> I (in Ref. 2; BAG57885).
FT                                {ECO:0000305}.
SQ   SEQUENCE   890 AA;  98664 MW;  781761FC47E9CEE7 CRC64;
     MNYVGQLAGQ VFVTVKELYK GLNPATLSGC IDIIVIRQPN GNLQCSPFHV RFGKMGVLRS
     REKVVDIEIN GESVDLHMKL GDNGEAFFVQ ETDNDQEVIP MHLATSPILS EGASRMECQL
     KRGSVDRMRG LDPSTPAQVI APSETPSSSS VVKKRRKRRR KSQLDSLKRD DNMNTSEDED
     MFPIEMSSDE AMELLESSRT LPNDIPPFQD DIPEENLSLA VIYPQSASYP NSDREWSPTP
     SPSGSRPSTP KSDSELVSKS TERTGQKNPE MLWLWGELPQ AAKSSSPHKM KESSPLSSRK
     ICDKSHFQAI HSESSDTFSD QSPTLVGGAL LDQNKPQTEM QFVNEEDLET LGAAAPLLPM
     IEELKPPSAS VVQTANKTDS PSRKRDKRSR HLGADGVYLD DLTDMDPEVA ALYFPKNGDP
     SGLAKHASDN GARSANQSPQ SVGSSGVDSG VESTSDGLRD LPSIAISLCG GLSDHREITK
     DAFLEQAVSY QQFVDNPAII DDPNLVVKIG SKYYNWTTAA PLLLAMQAFQ KPLPKATVES
     IMRDKMPKKG GRWWFSWRGR NTTIKEESKP EQCLAGKAHS TGEQPPQLSL ATRVKHESSS
     SDEERAAAKP SNAGHLPLLP NVSYKKTLRL TSEQLKSLKL KNGPNDVVFS VTTQYQGTCR
     CEGTIYLWNW DDKVIISDID GTITRSDTLG HILPTLGKDW THQGIAKLYH KVSQNGYKFL
     YCSARAIGMA DMTRGYLHWV NERGTVLPQG PLLLSPSSLF SALHREVIEK KPEKFKVQCL
     TDIKNLFFPN TEPFYAAFGN RPADVYSYKQ VGVSLNRIFT VNPKGELVQE HAKTNISSYV
     RLCEVVDHVF PLLKRSHSSD FPCSDTFSNF TFWREPLPPF ENQDIHSASA
//
